why choose us

First received: October 21, 2026

Clinical Trial: A Study to Evaluate the Effects of a Supplement on Gut Comfort in GLP-1 Receptor Agonist Users

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Gastrointestinal Discomfort
Gastrointestinal Side Effects of GLP-1 Receptor Agonist Use
Na

Study Type: INTERVENTIONAL


Official Title: A Study to Evaluate the Effects of a Supplement on Gut Comfort in GLP-1 Receptor Agonist Users

Brief Summary: This is a randomized, triple-blind, placebo-controlled, virtual clinical trial evaluating the effects of the Oxxynea® botanical supplement on gut comfort in adults who use GLP-1 receptor agonists (GLP-1 RAs). Seventy participants experiencing gastrointestinal discomfort associated with GLP-1 RA use will be randomized to receive either Oxxynea® or a matching placebo once daily for six weeks.Participants will complete questionnaires at Baseline, daily for the first 14 days, and at the end of Weeks 2, 4, and 6. The…

Read more